Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Net Income (2023 - 2025)

Metagenomi (MGX) has disclosed Net Income for 3 consecutive years, with -$22.5 million as the latest value for Q4 2025.

  • Quarterly Net Income rose 3.72% to -$22.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$87.9 million through Dec 2025, down 12.57% year-over-year, with the annual reading at -$87.9 million for FY2025, 12.57% down from the prior year.
  • Net Income for Q4 2025 was -$22.5 million at Metagenomi, down from -$20.4 million in the prior quarter.
  • The five-year high for Net Income was -$10.7 million in Q2 2024, with the low at -$25.1 million in Q1 2024.
  • Average Net Income over 3 years is -$19.1 million, with a median of -$19.9 million recorded in 2023.
  • Peak annual rise in Net Income hit 17.44% in 2024, while the deepest fall reached 114.23% in 2024.
  • Over 3 years, Net Income stood at -$19.3 million in 2023, then dropped by 21.27% to -$23.4 million in 2024, then rose by 3.72% to -$22.5 million in 2025.
  • According to Business Quant data, Net Income over the past three periods came in at -$22.5 million, -$20.4 million, and -$19.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.